[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fnz-CXYu2wSgn4Hhp52u5QFE0UeO75xsn5_HhQn7U2VU":8,"$fHj8RX_mXEDA56r2_F1I1M32_d5Ap1XmnLIxacngXNO0":56,"$fP5Y9SipvaPAfinQ6nnR6ai5tf_hW4D5WI5sz9E6NPCs":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},76533,867607,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//u4Kcsm8J23DFi9vsfDo509m3ezWIOgZe.png","戴振兴","盐城市第一人民医院","肿瘤科","主治医师",129,0,"乳腺癌治疗新突破：用药知识与转移管理指南","","https://ystcdn.venuertc.com/venue/AI/ec176ed4-3f29-477e-82f4-bf57535d8a29.jpg","\u003Ch1 id=\"material_title\" class=\"drug-title\">乳腺癌治疗新突破：用药知识与转移管理指南\u003C/h1>\n\n\u003Cdiv class=\"drug-intro\" style=\"background:linear-gradient(90deg,#F5F7FA 60%,#E9ECEF);padding:32px 28px 24px 28px;border-radius:14px;margin-bottom:36px;\">\n  \u003Cp>说到乳腺癌治疗用药，大家最常听到的就是“靶向治疗”以及“化疗药物”。其实，能够安全正确使用吡咯替尼、曲妥珠单抗、白蛋白紫杉醇这些药品，细节上非常关键。今天就分享7个用药重点，从服药方法到不良反应，让你快速掌握安全用药诀窍。\u003C/p>\n\u003C/div>\n\n\u003Csection class=\"drug-section\" style=\"margin-bottom:48px;background:linear-gradient(110deg,#E8F0FE 65%,#FFF);border-radius:14px;padding:24px 28px;\">\n  \u003Ch2 class=\"drug-section-title\">01 🕰️ 服用时间与方法：如何把握最佳用药时机？\u003C/h2>\n  \u003Cul class=\"drug-list\">\n    \u003Cli>\u003Cstrong>吡咯替尼片：\u003C/strong>建议每天同一时间口服，一般推荐早上或中午，避免空腹，宜饭后30分钟服用。这样可以减少胃肠刺激，提高药物吸收。\u003C/li>\n    \u003Cli>\u003Cstrong>曲妥珠单抗注射液：\u003C/strong>由医疗人员静脉滴注，初次给药需缓慢滴注，监测至少2小时。后续可根据耐受情况调整速度。\u003C/li>\n    \u003Cli>\u003Cstrong>白蛋白紫杉醇注射液：\u003C/strong>同样在医院静脉输注，通常用在化疗周期首日。用药前医师会根据体表面积计算剂量。\u003C/li>\n    \u003Cli>\u003Cstrong>伊尼妥单抗注射液：\u003C/strong>需在医疗机构下静脉滴注，首次用药多做过敏试验。\u003C/li>\n    \u003Cli>\u003Cstrong>正确做法：\u003C/strong>家用药片要定时间，注射类药物须由医疗专业人士操作。\u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"drug-section\" style=\"margin-bottom:48px;background:linear-gradient(120deg,#F1FAEE 70%,#E3F6FF);border-radius:14px;padding:24px 28px;\">\n  \u003Ch2 class=\"drug-section-title\">02 💊 剂型与服用技巧：每种药品如何正确使用？\u003C/h2>\n  \u003Cul class=\"drug-list\">\n    \u003Cli>\u003Cstrong>吡咯替尼：\u003C/strong>片剂，不可掰碎、溶解或嚼服，必须整片吞服并用至少100ml清水送服。\u003C/li>\n    \u003Cli>\u003Cstrong>曲妥珠单抗：\u003C/strong>是注射液，无口服剂型，需在医院由护士严格操作。\u003C/li>\n    \u003Cli>\u003Cstrong>白蛋白紫杉醇：\u003C/strong>输注前需摇匀，不得稀释不当，使用专用套管，避免塑化剂溶出。\u003C/li>\n    \u003Cli>\u003Cstrong>伊尼妥单抗：\u003C/strong>为冻干粉注射剂，需严格按照说明书复溶，无家用剂型。\u003C/li>\n    \u003Cli>\u003Cstrong>辅助用药如雷莫司琼：\u003C/strong>口服片应整片吞服，注射液仅限医护条件下使用。\u003C/li>\n    \u003Cli>\u003Cstrong>正确做法：\u003C/strong>家里药品不要自作主张拆分剂型或改变服用方式。\u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"drug-section\" style=\"margin-bottom:48px;background:linear-gradient(100deg,#E3F9E6 65%,#FA);border-radius:14px;padding:24px 28px;\">\n  \u003Ch2 class=\"drug-section-title\">03 🚦 药物相互作用：避免高风险联用\u003C/h2>\n  \u003Cul class=\"drug-list\">\n    \u003Cli>\u003Cstrong>吡咯替尼：\u003C/strong>不宜与强效CYP3A4抑制剂（如酮康唑、伊曲康唑）一同使用，否则可能加重副作用。与葡萄柚汁同饮也会影响代谢。\u003C/li>\n    \u003Cli>\u003Cstrong>曲妥珠单抗：\u003C/strong>与蒽环类药物联合时应定期做心脏功能监测，避免心脏损害。\u003C/li>\n    \u003Cli>\u003Cstrong>白蛋白紫杉醇：\u003C/strong>不建议与其他骨髓抑制药物合用，会增加骨髓抑制风险。与抗肿瘤药物联用需严格执行医院方案。\u003C/li>\n    \u003Cli>\u003Cstrong>辅助药品如氢化泼尼松：\u003C/strong>与某些糖皮质激素、免疫抑制剂联用时须遵循医嘱。\u003C/li>\n    \u003Cli>\u003Cstrong>正确做法：\u003C/strong>不自行添加保健品或新药种，服药期间告知医生所有已用药品。\u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"drug-section\" style=\"margin-bottom:48px;background:linear-gradient(100deg,#FFE8E5 60%,#FFF5F0);border-radius:14px;padding:24px 28px;\">\n  \u003Ch2 class=\"drug-section-title\">04 🧑‍🦳 特殊人群用药：针对个体调整\u003C/h2>\n  \u003Cul class=\"drug-list\">\n    \u003Cli>\u003Cstrong>老年患者：\u003C/strong>应每周期评估肝肾功能，根据医生建议考虑吡咯替尼、白蛋白紫杉醇等药物适度减量；曲妥珠单抗用量由体重决定，老人应精确称量。\u003C/li>\n    \u003Cli>\u003Cstrong>肝功能异常：\u003C/strong>如近期肝功能波动，须减少吡咯替尼等口服药物剂量，曲妥珠单抗注射量同样需调整。\u003C/li>\n    \u003Cli>\u003Cstrong>肾功能不全：\u003C/strong>对大多数化疗药物都有影响，要及时告知医生并监控血生化指标。\u003C/li>\n    \u003Cli>\u003Cstrong>孕妇、哺乳期女性：\u003C/strong>均禁用吡咯替尼、白蛋白紫杉醇、曲妥珠单抗，使用前务必避孕。\u003C/li>\n    \u003Cli>\u003Cstrong>正确做法：\u003C/strong>用药前向医生全面报告既往用药及基础健康状况。\u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"drug-section\" style=\"margin-bottom:48px;background:linear-gradient(90deg,#F6F0FF 70%,#F9F9F9);border-radius:14px;padding:24px 28px;\">\n  \u003Ch2 class=\"drug-section-title\">05 💥 常见不良反应：识别与应对方法\u003C/h2>\n  \u003Cul class=\"drug-list\">\n    \u003Cli>\u003Cstrong>吡咯替尼：\u003C/strong>说明书提示最常见为腹泻（发生率约85%），如大便次数增加须及时补液并告知医生。\u003C/li>\n    \u003Cli>\u003Cstrong>曲妥珠单抗：\u003C/strong>部分患者静脉注射时出现发热、寒战、心悸。如发现呼吸急促、胸痛应立即叫医护人员。\u003C/li>\n    \u003Cli>\u003Cstrong>白蛋白紫杉醇：\u003C/strong>短期内反应多为脱发、骨髓抑制，极少发生过敏性休克。\u003C/li>\n    \u003Cli>\u003Cstrong>伊尼妥单抗：\u003C/strong>可能有注射部位红肿、发热。输液前要求做过敏试验。\u003C/li>\n    \u003Cli>\u003Cstrong>辅助药如雷莫司琼：\u003C/strong>有少量患者用药后出现便秘。\u003C/li>\n    \u003Cli>\u003Cstrong>正确做法：\u003C/strong>出现腹泻或呼吸异常立即联系医生，所有副作用须主动报告。\u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"drug-section\" style=\"margin-bottom:48px;background:linear-gradient(90deg,#FFDDEA 70%,#FFF3F8);border-radius:14px;padding:24px 28px;\">\n  \u003Ch2 class=\"drug-section-title\">06 📦 储存方法与有效期：保证药品质量\u003C/h2>\n  \u003Cul class=\"drug-list\">\n    \u003Cli>\u003Cstrong>吡咯替尼片：\u003C/strong>需置阴凉干燥处，避光密封储存，尽量不要存放于浴室、厨房等潮湿环境。\u003C/li>\n    \u003Cli>\u003Cstrong>曲妥珠单抗注射液：\u003C/strong>冷藏（2-8°C），开封后如未用完，须丢弃剩余药物。\u003C/li>\n    \u003Cli>\u003Cstrong>白蛋白紫杉醇：\u003C/strong>未开瓶原液需冷藏保存，稀释后6小时内必须用完，不得留存。\u003C/li>\n    \u003Cli>\u003Cstrong>伊尼妥单抗冻干粉：\u003C/strong>冷藏条件下储存，避免反复开关，防止药品变质。\u003C/li>\n    \u003Cli>\u003Cstrong>其他辅助药：\u003C/strong>根据说明书储存，一般避光、干燥是基本原则。\u003C/li>\n    \u003Cli>\u003Cstrong>正确做法：\u003C/strong>每次用药前检查有效期，过期药品必须丢弃禁止使用。\u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"drug-section\" style=\"margin-bottom:48px;background:linear-gradient(95deg,#F3F9FF 65%,#F6F4F2);border-radius:14px;padding:24px 28px;\">\n  \u003Ch2 class=\"drug-section-title\">07 ⚠️ 漏服与过量处理：遇到意外该怎么办？\u003C/h2>\n  \u003Cul class=\"drug-list\">\n    \u003Cli>\u003Cstrong>吡咯替尼片：\u003C/strong>如漏服，可以尽快补服，但距离下次服药小于6小时则不补服。如服用过量，需立即就医。\u003C/li>\n    \u003Cli>\u003Cstrong>曲妥珠单抗：\u003C/strong>注射类药物按计划完成即可，漏一次无需追补，应从下次正常剂量继续。过量给药应立即医院处理。\u003C/li>\n    \u003Cli>\u003Cstrong>白蛋白紫杉醇与伊尼妥单抗：\u003C/strong>漏服需顺延至下个周期，有过量表现（如严重骨髓抑制），需紧急医疗干预。\u003C/li>\n    \u003Cli>\u003Cstrong>正确做法：\u003C/strong>不随意加量或减少用药，遇到错误用药行为应及时告知医护。\u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Cdiv class=\"drug-case-section\" style=\"margin-bottom:52px;padding:32px 28px;background:linear-gradient(88deg,#FCF6E3 90%,#FFF9F2);border-radius:14px;\">\n  \u003Ch2 class=\"drug-case-title\">🌿 临床用药案例\u003C/h2>\n  \u003Cul class=\"drug-case-list\">\n    \u003Cli>一位55岁女性在连续联合用药（吡咯替尼+曲妥珠单抗+白蛋白紫杉醇）期间，严格按量、分周期服用，未出现严重不良反应，病情稳定。\u003C/li>\n    \u003Cli>临床中部分患者于曲妥珠单抗注射前做心功能评估，避免心脏副作用，辅以补液和止吐药物支持，有效提升安全性。\u003C/li>\n    \u003Cli>老年患者调整吡咯替尼剂量后，腹泻症状明显减轻，顺利完成下一周期治疗。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\n\u003Cdiv class=\"drug-summary\" style=\"background:linear-gradient(90deg,#F5F7FA 70%,#DAEFFF);border-radius:14px;padding:32px 28px;\">\n  \u003Ch2 class=\"drug-summary-title\">🔑 总结与建议\u003C/h2>\n  \u003Cul class=\"drug-summary-list\">\n    \u003Cli>正确的用药方法，包含定时服药、剂型不拆分、医院专业注射、严格监控用量等，是安全治疗的关键。\u003C/li>\n    \u003Cli>任何不良反应要及时上报，遇到漏服或用错药量，第一时间联系医生切勿自作主张。\u003C/li>\n    \u003Cli>储存、相互作用和特殊人群调整都不可忽视，大剂量服药和过期药品必须坚决避免。\u003C/li>\n    \u003Cli>合理遵循药品说明书和医院用药方案，比任何“个人经验”更值得信赖。\u003C/li>\n  \u003C/ul>\n  \u003Cp style=\"margin-top:20px;\">安全用药是好效果的保障，如有疑问，建议随时咨询专业医师和药师。\u003C/p>\n\u003C/div>\n\n\n\u003Cdiv class=\"drug-literature\" style=\"padding:28px 22px;background:linear-gradient(112deg,#FDFDFA 85%,#F8FAFB);border-radius:14px;margin-bottom:20px;\">\n  \u003Ch2 class=\"drug-literature-title\">🔍 参考文献\u003C/h2>\n  \u003Col class=\"drug-literature-list\">\n    \u003Cli>Xu, B., et al. (2019). Pyrotinib in HER2‐positive metastatic breast cancer: a multicenter, randomized, controlled phase II trial. \u003Cem>Journal of Clinical Oncology\u003C/em>, 37(27), 2610–2619.\u003C/li>\n    \u003Cli>Baselga, J., et al. (2012). Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 366(2), 109-119.\u003C/li>\n    \u003Cli>Gradishar, W.J., et al. (2013). Albumin-bound paclitaxel versus polyethylated castor oil–based paclitaxel in metastatic breast cancer: Phase III ENHANCE trial. \u003Cem>Journal of Clinical Oncology\u003C/em>, 31(17), 1995–2001.\u003C/li>\n  \u003C/ol>\n\u003C/div>\n\n\u003Cstyle>\n.drug-title {\n  font-size: 42px;\n  font-weight: bold;\n  letter-spacing: 2px;\n  color: #345a79;\n  margin-bottom: 38px;\n  font-family: 'Segoe UI','PingFang SC','Arial',sans-serif;\n}\n.drug-intro {\n  font-size: 21px;\n  color: #425063;\n  margin-top: 0;\n  border-left: 8px solid #99b6df;\n}\n.drug-section {\n  box-shadow: 0 8px 22px rgba(90,120,190,0.07);\n}\n.drug-section-title {\n  font-size: 31px;\n  font-weight: bold;\n  color: #7D3FC3;\n  margin-top: 0;\n  margin-bottom: 22px;\n  letter-spacing: 1px;\n  background-repeat: no-repeat;\n  background-position: right 11px top 22px;\n  font-family: 'Segoe UI','PingFang SC','Arial',sans-serif;\n}\n.drug-list {\n  margin-left: 18px;\n  font-size: 20px;\n  color: #364553;\n  line-height: 1.8;\n  padding-left: 0;\n}\n.drug-list strong {\n  color:#456bbb;\n}\n.drug-case-section {\n  border-left: 8px solid #FAA8A0;\n  box-shadow: 0 6px 16px rgba(240,150,110,0.12);\n}\n.drug-case-title {\n  font-size: 27px;\n  color: #EA5278;\n  font-weight: bold;\n  margin-bottom: 14px;\n}\n.drug-case-list {\n  margin-left: 16px;\n  font-size: 19px;\n  color: #654e35;\n  line-height: 1.7;\n}\n.drug-data-section {\n  border-left: 8px solid #65B8F6;\n  box-shadow: 0 8px 28px rgba(110,180,240,0.15);\n}\n.drug-data-title {\n  font-size: 27px;\n  color: #3380C6;\n  font-weight: bold;\n  margin-bottom: 14px;\n}\n.drug-data-list {\n  margin-left: 18px;\n  font-size: 20px;\n  color: #375c6a;\n  line-height: 1.7;\n}\n.drug-summary {\n  box-shadow: 0 12px 32px rgba(80,105,130,0.10);\n  border-left: 8px solid #67A8BE;\n}\n.drug-summary-title {\n  font-size: 29px;\n  color: #38889a;\n  font-weight: bold;\n  margin-bottom: 10px;\n}\n.drug-summary-list {\n  margin-left: 18px;\n  font-size: 20px;\n  color: #315e5e;\n  line-height: 1.7;\n}\n.drug-literature {\n  border-left: 8px solid #AAA5E7;\n}\n.drug-literature-title {\n  font-size: 25px;\n  color: #72549B;\n  font-weight: bold;\n}\n.drug-literature-list {\n  font-size: 17px;\n  color: #555;\n  margin-left: 14px;\n  line-height: 1.6;\n}\n@media screen and (max-width:700px) {\n  .drug-title {font-size:26px;}\n  .drug-section-title,\n  .drug-case-title,\n  .drug-data-title,\n  .drug-summary-title,\n  .drug-literature-title {font-size:18px;}\n  .drug-intro, .drug-list, .drug-case-list, .drug-data-list, .drug-summary-list, .drug-literature-list {font-size:15px;}\n  .drug-section, .drug-case-section, .drug-data-section, .drug-summary, .drug-literature {padding:10px;}\n}\n\u003C/style>","\u003Ch1 id=\"material_title\" class=\"drug-title\">乳腺癌治疗新突破：用药知识与转移管理指南\u003C/h1>\n\n\u003Cdiv class=\"drug-intro\" style=",564,"2025-12-13 01:19:32"," 乳腺癌治疗新突破：用药知识与转移管理指南 - 最新疗法与护理建议  \n"," 乳腺癌治疗, 乳腺癌用药指南, 乳腺癌转移管理, 最新乳腺癌疗法, 乳腺癌护理建议, 乳腺癌康复  \n"," 本文提供乳腺癌治疗的最新突破，包括用药知识、转移管理策略及护理建议。了解前沿疗法，掌握科学康复方法，帮助患者和家属更好地应对乳腺癌挑战。","2025-12-27 18:21:45",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]